Aier Eye Hospital Group Co., Ltd. (SHE:300015)

Market Cap	89.05B -33.2%
Revenue (ttm)	22.17B +7.5%
Net Income	3.22B -11.3%
EPS	0.35 -11.3%
Shares Out	9.30B
PE Ratio	27.57
Forward PE	22.05
Dividend	0.16 (1.66%)
Ex-Dividend Date	Jan 15, 2026

Volume	54,378,600
Average Volume	50,471,967
Open	9.51
Previous Close	9.62
Day's Range	9.51 - 9.64
52-Week Range	9.32 - 13.95
Beta	0.52
RSI	41.72
Earnings Date	Apr 24, 2026

About Aier Eye Hospital Group

Aier Eye Hospital Group Co., Ltd. operates as a ophthalmology chain medical company in China, Hong Kong, Europe, the United States, and Southeast Asia. The company offers diagnosis and treatment of various ophthalmic diseases, surgical services, medical optometry, and glasses for fundus diseases, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. Aier Eye Hospital Group Co., Ltd. was founded in 2002 and is headquartered in Changsha, China.

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2002
• Employees: 42,693
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300015

Financial Performance

In 2024, Aier Eye Hospital Group's revenue was 20.98 billion, an increase of 3.02% compared to the previous year's 20.37 billion. Earnings were 3.56 billion, an increase of 5.87%.